NCT06727253View on ClinicalTrials.gov

Glycan Supplementation on a Human Model of Crohn's Disease Initiation and Progression

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 26, 2025

Primary Completion Date

June 1, 2028

Study Completion Date

December 1, 2028

Conditions
Crohn Disease (CD)
Interventions
DIETARY_SUPPLEMENT

Glycan

The post-operative CD patients will receive an orally administered glycan.

Trial Locations (1)

1500-650

RECRUITING

Hospital da Luz Lisboa, Lisbon

All Listed Sponsors
lead

GLSMED Learning Health S.A.

OTHER

NCT06727253 - Glycan Supplementation on a Human Model of Crohn's Disease Initiation and Progression | Biotech Hunter | Biotech Hunter